or Try an Advanced Search...

    Technical Analysis for BCDA - BioCardia, Inc.

    Grade Last Price % Change Price Change
    F 2.99 0.67% 0.02
    BCDA closed up 0.67 percent on Monday, July 1, 2024, on 4 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Very Strong Down Down Down
    Historical BCDA trend table...
    Date Alert Name Type % Chg
    MACD Bullish Signal Line Cross Bullish 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Wide Bands Range Expansion 0.67%
    Oversold Stochastic Weakness 0.67%
    Slingshot Bearish Bearish Swing Setup 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Older End-of-Day Signals for BCDA ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 7 hours ago
    Fell Below Previous Day's Low about 8 hours ago
    Down 2 % about 8 hours ago
    Down 1% about 8 hours ago
    60 Minute Opening Range Breakdown about 10 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    BCDA Chart by TradingView
    Basic chart:

    Profile

    BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapeutics for cardiovascular diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia. The company is also developing CardiALLO Cell Therapy System, an investigational culture expanded bone marrow derived from mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic systolic heart failure. In addition, it offers the Helix biotherapeutic delivery system; and Morph vascular access product line, which provides catheter products. BioCardia, Inc. is based in San Carlos, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Life Sciences Biology Bone Stem Cell Cell Therapy Catheter Cardiovascular Disease Heart Failure Vascular Disease Regenerative Medicine Heart Disease Vascular Access Products Bone Marrow Aging Associated Diseases Ischemia Treatment Of Heart Failure

    Is BCDA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 10 Why KKR Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
    Jun 7 What's Going with BioCardia Stock Friday?
    Jun 7 BioCardia gets US patent for radial transendocardial technology
    Jun 7 BioCardia Announces United States Patent Issuance on Intramyocardial Delivery of Cell Aggregates to the Heart Including Minimally Invasive Radial Artery Approach
    May 21 BioCardia intends to effect reverse stock split
    May 21 BioCardia Announces Reverse Stock Split
    May 15 BioCardia Inc (BCDA) Q1 2024 Earnings Call Transcript Highlights: Strategic Progress Amid ...
    May 15 BioCardia, Inc. (BCDA) Q1 2024 Earnings Call Transcript
    May 14 BioCardia GAAP EPS of -$0.09, revenue of $0.05M
    May 14 BioCardia Reports First Quarter 2024 Business Highlights and Financial Results
    See more BCDA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 43.1685
    52 Week Low 2.62
    Average Volume 166,610
    200-Day Moving Average 6.70
    50-Day Moving Average 4.75
    20-Day Moving Average 3.50
    10-Day Moving Average 3.09
    Average True Range 0.42
    RSI (14) 24.81
    ADX 56.49
    +DI 9.50
    -DI 24.47
    Chandelier Exit (Long, 3 ATRs) 4.43
    Chandelier Exit (Short, 3 ATRs) 3.88
    Upper Bollinger Bands 4.56
    Lower Bollinger Band 2.44
    Percent B (%b) 0.26
    BandWidth 60.51
    MACD Line -0.56
    MACD Signal Line -0.57
    MACD Histogram 0.0145
    Fundamentals Value
    Market Cap 70.62 Million
    Num Shares 23.6 Million
    EPS -0.62
    Price-to-Earnings (P/E) Ratio -4.82
    Price-to-Sales 17.62
    Price-to-Book 10.67
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.24
    Resistance 3 (R3) 3.24 3.16 3.20
    Resistance 2 (R2) 3.16 3.09 3.16 3.19
    Resistance 1 (R1) 3.07 3.05 3.03 3.07 3.17
    Pivot Point 2.99 2.99 2.96 2.99 2.99
    Support 1 (S1) 2.90 2.92 2.86 2.91 2.81
    Support 2 (S2) 2.82 2.88 2.82 2.79
    Support 3 (S3) 2.73 2.82 2.78
    Support 4 (S4) 2.74